Panc 02.03/iRFP cells are derived from the human pancreatic cancer cell line Panc 02.03 by stably integration of a constitutive miRFP670 stably expression construct. Panc 02.03 cells have been used in research to study pancreatic cancer biology, treatment responses, and drug development. Panc 02.03/iRFP cells stably express miRFP670, can be used for in vitro assays and in vivo imaging.